Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Humanwell Narita Pharmaceutical is a specialized pharmaceutical manufacturer based in Jingmen, Hubei Province, China, and operates as a key subsidiary of Humanwell Healthcare Group. The company focuses primarily on the research, development, and production of external and topical medications, maintaining a leading position in the Chinese dermatology market. Its flagship product, Youzhuoer (Hydrocortisone Butyrate Cream), is one of the most widely recognized corticosteroid treatments in China for inflammatory skin conditions. The company's portfolio includes a diverse range of formulations such as creams, ointments, gels, and solutions targeting eczema, fungal infections, and acne. Humanwell Narita operates modern, GMP-certified manufacturing facilities and leverages the extensive distribution network of its parent company to reach healthcare providers nationwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 湖北人福成田药业.